Alembic Pharmaceuticals Ltd Half Yearly Results

Gross Sales

3,620.87

3,462.37

3,209.71

3,147.55

3,081.08

Excise Duty

0

0

0

0

0

Net Sales

3,620.87

3,462.37

3,209.71

3,147.55

3,081.08

Other Operating Income

0

0

0

0

0

Other Income

14.38

23.39

32.9

6.49

21.82

Total Income

3,635.25

3,485.76

3,242.61

3,154.04

3,102.9

Total Expenditure

3,023.83

2,930.22

2,733.62

2,621.57

2,674.68

PBIDT

611.42

555.54

508.99

532.47

428.22

Interest

47.75

46.78

31.99

26.11

30.08

PBDT

563.67

508.76

477

506.36

398.14

Depreciation

149.84

139.03

139.55

138.93

133.74

Minority Interest Before NP

0

0

0

0

0

Tax

68.81

43.13

79.05

54.22

7.84

Deferred Tax

7.68

32.28

-29.29

-45.45

-0.6

Reported Profit After Tax

337.34

294.32

287.69

358.66

257.16

Minority Interest After NP

-1.75

-0.98

-0.43

0

0

Net Profit after Minority Interest

339.09

295.3

288.12

358.66

257.16

Extra-ordinary Items

0

0

9.86

0

0

Adjusted Profit After Extra-ordinary item

339.09

295.3

278.26

358.66

257.16

EPS (Unit Curr.)

17.25

15.02

14.64

18.25

13.08

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

39.31

39.31

39.31

39.31

39.31

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

16.88

16.04

15.85

16.91

13.89

PBDTM(%)

-

-

-

-

-

PATM(%)

9.31

8.5

8.96

11.39

8.34